Cytokinetics Inc Earnings

Cytokinetics Inc’s revenue jumped 26714.86% since last year same period to $66.77Mn in the Q2 2025. On a quarterly growth basis, Cytokinetics Inc has generated 4128.56% jump in its revenue since last 3-months.

Cytokinetics Inc’s net profit jumped 6.24% since last year same period to $-134.37Mn in the Q2 2025. On a quarterly growth basis, Cytokinetics Inc has generated 16.73% jump in its net profits since last 3-months.

Cytokinetics Inc’s net profit margin jumped 99.65% since last year same period to -201.25% in the Q2 2025. On a quarterly growth basis, Cytokinetics Inc has generated 98.03% jump in its net profit margins since last 3-months.

Cytokinetics Inc’s earning per share (EPS) estimates for the current quarter stand at -1.56 - a -9.86% fall from last quarter’s estimates.

Cytokinetics Inc’s earning per share (EPS) estimates for the current year stand at -1.56.

Cytokinetics Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Cytokinetics Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.